Filing Details

Accession Number:
0001178913-16-005648
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-06-06 16:01:29
Reporting Period:
2016-05-30
Filing Date:
2016-06-06
Accepted Time:
2016-06-06 16:01:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1158780 Pluristem Therapeutics Inc PSTI Biological Products, (No Disgnostic Substances) (2836) 980351734
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1268788 Doron Shorrer 33 Khore Hadorot St
Jerusalem L3 93393
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-05-30 12,346 $1.52 570,208 No 4 S Indirect By Shorrer International Ltd
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Shorrer International Ltd
Footnotes
  1. The sale was effected on the Tel Aviv Stock Exchange in New Israeli Shekels (NIS) for a per share sales price of NIS 5.85, which per share purchase price has been reported on this Form 4 in U.S. dollars based on an exchange rate of NIS 3.845 per U.S. dollar.
  2. The reporting person's sale of 12,346 shares of PSTI common stock reported herein is matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, with the reporting person's purchase of 12,346 shares of PSTI common stock reported on February 17, 2016. The reporting person has paid PSTI, $8,816.28 representing the full amount of the profit realized in connection with these short-swing transactions.